Self-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: A cross-sectional survey

International Journal of Nursing Studies

Volumn 48, Issue 12, 2011, Pages 1540-1550

  De Smedt, Ruth H E ^a   Denig, Petra ^a   van der Meer, Klaas ^a   Haaijer Ruskamp, Flora M ^a   Jaarsma, Tiny ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adverse effects; Cardiovascular disease; Illness perception; Medication beliefs

Indexed keywords

CARDIOVASCULAR AGENT;

AGED; AMBULATORY CARE; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEART FAILURE; HUMAN; ILLNESS BEHAVIOR; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; CARDIOVASCULAR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; ILLNESS BEHAVIOR; MALE; MIDDLE AGED;

EID: 81855170110     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2011.05.014     Document Type: Article

References (53)

1. Aalto A.M., Aro A.R., Weinman J., Heijmans M., Manderbacka K., Elovainio M. Sociodemographic, disease status, and illness perceptions predictors of global self-ratings of health and quality of life among those with coronary heart disease-one year follow-up study. Quality of Life Research 2006, 15(8):1307-1322.
2. Aalto A.M., Heijmans M., Weinman J., Aro A.R. Illness perceptions in coronary heart disease. Sociodemographic, illness-related, and psychosocial correlates. Journal of Psychosomatic Research 2005, 58(5):393-402.
3. American Heart Association Heart Disease and Stroke Statistics, 2009 Update 2009, American Heart Association, Dallas, TX.
4. Basch E., Jia X., Heller G., Barz A., Sit L., Fruscione M., Appawu M., Iasonos A., Atkinson T., Goldfarb S., Culkin A., Kris M.G., Schrag D. Adverse symptom event reporting by patients versus clinicians: relationships with clinical outcomes. Journal of the National Cancer Institute 2009, 101(23):1624-1632.
5. Blue L., McMurray J. How much responsibility should heart failure nurses take?. European Journal of Heart Failure 2005, 7(3):351-361.
6. Bosch M., Wensing M., Bakx J.C., van der W.T., Hoes A.W., Grol R.P. Current treatment of chronic heart failure in primary care; still room for improvement. Journal of Evaluation in Clinical Practice 2010, 16(3):644-650.
7. De Smedt R.H., Denig P., Haaijer-Ruskamp F.M., Jaarsma T. Perceived medication adverse effects and coping strategies reported by chronic heart failure patients. International Journal of Clinical Practice 2009, 63(2):233-242.
8. De Smedt R.H.E., Jaarsma T., Haaijer-Ruskamp F.M., Denig P. The impact of perceived adverse effects on medication changes in heart failure patients. Journal of Cardiac Failure 2010, 16(2). 135-141.e2.
9. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., Stromberg A., van Veldhuisen D.J., Atar D., Hoes A.W., Keren A., Mebazaa A., Nieminen M., Priori S.G., Swedberg K., Vahanian A., Camm J., De C.R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., Zamorano J.L., Tendera M., Auricchio A., Bax J., Bohm M., Corra U., della B.P., Elliott P.M., Follath F., Gheorghiade M., Hasin Y., Hernborg A., Jaarsma T., Komajda M., Kornowski R., Piepoli M., Prendergast B., Tavazzi L., Vachiery J.L., Verheugt F.W., Zamorano J.L., Zannad F. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Journal of Heart Failure 2008, 10(10):933-989.
10. Fagerland M.W., Sandvik L. Performance of five two-sample location tests for skewed distributions with unequal variances. Contemporary Clinical Trials 2009, 30(5):490-496.
11. Field T.S., Gurwitz J.H., Harrold L.R., Rothschild J., DeBellis K.R., Seger A.C., Auger J.C., Garber L.A., Cadoret C., Fish L.S., Garber L.D., Kelleher M., Bates D.W. Risk factors for adverse drug events among older adults in the ambulatory setting. Journal of American Geriatric Society 2004, 52(8):1349-1354.
12. Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K., Bates D.W. Adverse drug events occurring following hospital discharge. Journal of General Internal Medicine 2005, 20(4):317-323.
13. French D.P., Cooper A., Weinman J. Illness perceptions predict attendance at cardiac rehabilitation following acute myocardial infarction: a systematic review with meta-analysis. Journal of Psychosomatic Research 2006, 61(6):757-767.
14. Gandhi T.K., Weingart S.N., Borus J., Seger A.C., Peterson J., Burdick E., Seger D.L., Shu K., Federico F., Leape L.L., Bates D.W. Adverse drug events in ambulatory care. New England Journal of Medicine 2003, 348(16):1556-1564.
15. Garavalia L., Garavalia B., Spertus J.A., Decker C. Exploring patients' reasons for discontinuance of heart medications. Journal of Cardiovascular Nursing 2009, 24(5):371-379.
16. Gehi A.K., Ali S., Na B., Whooley M.A. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Archives of Internal Medicine 2007, 167(16):1798-1803.
17. Green J.L., Hawley J.N., Rask K.J. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?. American Journal of Geriatric Pharmacotherapy 2007, 5(1):31-39.
18. Hanlon J.T., Maher R.L., Lindblad C.I., Ruby C.M., Twersky J., Cohen H.J., Schmader K.E. Comparison of methods for detecting potential adverse drug events in frail elderly inpatients and outpatients. American Journal of Health-System Pharmacy 2001, 58(17):1622-1626.
19. Hanlon J.T., Schmader K.E., Koronkowski M.J., Weinberger M., Landsman P.B., Samsa G.P., Lewis I.K. Adverse drug events in high risk older outpatients. Journal of American Geriatric Society 1997, 45(8):945-948.
20. Ho P.M., Magid D.J., Shetterly S.M., Olson K.L., Maddox T.M., Peterson P.N., Masoudi F.A., Rumsfeld J.S. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. American Heart Journal 2008, 155(4):772-779.
21. Hope C.J., Wu J., Tu W., Young J., Murray M.D. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. American Journal of Health-System Pharmacy 2004, 61(19):2043-2049.
22. Horne R., Weinman J., Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health 1999, 14(1):1-24.
23. Jaarsma T., van der Wal M.H., Lesman-Leegte I., Luttik M.L., Hogenhuis J., Veeger N.J., Sanderman R., Hoes A.W., van Gilst W.H., Lok D.J., Dunselman P.H., Tijssen J.G., Hillege H.L., van Veldhuisen D.J. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Archives of Internal Medicine 2008, 168(3):316-324.
24. Kostis J.B., Shelton B.J., Yusuf S., Weiss M.B., Capone R.J., Pepine C.J., Gosselin G., Delahaye F., Probstfield J.L., Cahill L. Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction. American Heart Journal 1994, 128(2):358-364.
25. Lakhdar R., Al-Mallah M.H., Lanfear D.E. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials. Journal of Cardiac Failure 2008, 14(3):181-188.
26. Lampela P., Hartikainen S., Sulkava R., Huupponen R. Adverse drug effects in elderly people-a disparity between clinical examination and adverse effects self-reported by the patient. European Journal of Clinical Pharmacology 2007, 63(5):509-515.
27. Lane D.A., Langman C.M., Lip G.Y., Nouwen A. Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. Journal of Psychosomatic Research 2009, 66(3):203-210.
28. Michalsen A., Konig G., Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 1998, 80(5):437-441.
29. Molloy G.J., Gao C., Johnston D.W., Johnston M., Witham M.D., Struthers A.D., McMurdo M.E. Adherence to angiotensin-converting-enzyme inhibitors and illness beliefs in older heart failure patients. European Journal of Heart Failure 2009, 11(7):715-720.
30. Moss-Morris R., Weinman J., Petrie K.J., Horne R., Cameron L.D., Buick D. The revised Illness Perception Questionnaire (IPQ-R). Psychology and Health 2002, 17(1):1-16.
31. Muzzarelli S., Brunner-La Rocca H., Pfister O., Foglia P., Moschovitis G., Mombelli G., Stricker H. Adherence to medical regime in patients with heart failure. European Journal of Heart Failure 2010, 12(4):389-396.
32. Oladimeji O., Farris K.B., Urmie J.G., Doucette W.R. Risk factors for self-reported adverse drug events among Medicare enrollees. Annals of Pharmacotherapy 2008, 42(1):53-61.
33. Oladimeji O., Farris K.B., Urmie J.G., Doucette W.R. Symptomatology, attribution to medicines, and symptom reporting among Medicare enrollees. Research in Social Administrative Pharmacy 2009, 5(3):225-233.
34. Pattenden J.F., Roberts H., Lewin R.J. Living with heart failure; patient and carer perspectives. European Journal of Cardiovascular Nursing 2007, 6(4):273-279.
35. Rief W., Avorn J., Barsky A.J. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Archives of Internal Medicine 2006, 166(2):155-160.
36. Roberts M.E., Epstein B.J. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner. Journal of Cardiovascular Nursing 2009, 24(5):380-389.
37. Rogers A., Addington-Hall J.M., McCoy A.S., Edmonds P.M., Abery A.J., Coats A.J., Gibbs J.S. A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. European Journal of Heart Failure 2002, 4(3):283-287.
38. Rosmalen J.G., Neeleman J., Gans R.O., de Jonge J.P. The association between neuroticism and self-reported common somatic symptoms in a population cohort. Journal of Psychosomatic Research 2007, 62(3):305-311.
39. Routledge P.A., O'Mahony M.S., Woodhouse K.W. Adverse drug reactions in elderly patients. British Journal of Clinical Pharmacology 2004, 57(2):121-126.
40. Sheftell F.D., Feleppa M., Tepper S.J., Rapoport A.M., Ciannella L., Bigal M.E. Assessment of adverse events associated with triptans-methods of assessment influence the results. Headache 2004, 44(10):978-982.
41. Shi S., Morike K., Klotz U. The clinical implications of ageing for rational drug therapy. European Journal of Clinical Pharmacology 2008, 64(2):183-199.
42. Shiyanbola O.O., Farris K.B. Concerns and beliefs about medicines and inappropriate medications: an internet-based survey on risk factors for self-reported adverse drug events among older adults. American Journal of Geriatric Pharmacotherapy 2010, 8(3):245-257.
43. Smith O.R., Pedersen S.S., Van Domburg R.T., Denollet J. Symptoms of fatigue and depression in ischemic heart disease are driven by personality characteristics rather than disease stage: a comparison of CAD and CHF patients. European Journal of Cardiovascular Prevention and Rehabilitation 2008, 15(5):583-588.
44. Stafford L., Berk M., Jackson H.J. Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes?. Journal of Psychosomatic Research 2009, 66(3):211-220.
45. Tangiisuran B., Wright J., Van der C.T., Rajkumar C. Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age and Ageing 2009, 38:358-359.
46. van Buuren S., Boshuizen H.C., Knook D.L. Multiple imputation of missing blood pressure covariates in survival analysis. Statistics in Medicine 1999, 18(6):681-694.
47. van den Bemt P.M., Egberts A.C., Lenderink A.W., Verzijl J.M., Simons K.A., van der Pol W.S., Leufkens H.G. Risk factors for the development of adverse drug events in hospitalized patients. Pharmacy World & Science 2000, 22(2):62-66.
48. van der Wal M.H., Jaarsma T., Moser D.K., Veeger N.J., van Gilst W.H., van Veldhuisen D.J. Compliance in heart failure patients: the importance of knowledge and beliefs. European Heart Journal 2006, 27(4):434-440.
49. van der Wal M.H., Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. International Journal of Cardiology 2008, 125(2):203-208.
50. van der Wal M.H., Jaarsma T., Moser D.K., van Gilst W.H., van Veldhuisen D.J. Qualitative examination of compliance in heart failure patients in The Netherlands. Heart & Lung 2010, 39(2):121-130.
51. Wallander M.A., Dimenas E., Svardsudd K., Wiklund I. Evaluation of three methods of symptom reporting in a clinical trial of felodipine. European Journal of Clinical Pharmacology 1991, 41(3):187-196.
52. Welstand J., Carson A., Rutherford P. Living with heart failure: an integrative review. International Journal of Nursing Studies 2009, 46(10):1374-1385.
53. Recommendations guiding physicians in biomedical research involving human subjects. Journal of the American Medical Association 1997, 277(11):925-926.